CoChat
Sign Up
Cited by 136Cervical Cancer and HPV ResearchWomen's cancer prevention and managementVaccine Coverage and Hesitancy

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts

Sankaranarayanan, Rengaswamy, Basu, Partha, Kaur, Prabhdeep, Bhaskar, Rajesh, Singh, Gurinder Bir, Denzongpa, Phumzay, Grover, Rajesh K, Sebastian, Paul, Saikia, Tapan, Oswal, Kunal, Kanodia, Rishav, Dsouza, Amantia, Mehrotra, Ravi, Rath, Goura Kishor, Jaggi, Viniita, Kashyap, Sundram, Kataria, Ishu, Hariprasad, Roopa, Sasieni, Peter, Bhatla, Neerja, Rajaraman, Preetha, Trimble, Edward L, Swaminathan, Soumya, Purushotham, Arnie·2019·The Lancet Oncology
DOI 10.1016/s1470-2045(19)30531-5
Open this paper in CoChat — free account

Abstract

Efforts are being made to scale up human papillomavirus (HPV) vaccination for adolescent girls in India. Bivalent and quadrivalent HPV vaccines were licensed in the country in 2008, and a nonavalent vaccine was licensed in 2018. Demonstration projects initiated in Andhra Pradesh and Gujarat in 2009 introduced HPV vaccination in public health services in India. Following a few deaths in these projects, although subsequently deemed unrelated to vaccination, HPV vaccination in research projects was suspended. This suspension by default resulted in some participants in a trial evaluating two versus three doses receiving only one dose. Since 2016, the successful introduction of HPV vaccination in immunisation programmes in Punjab and Sikkim (with high coverage and safety), government-sponsored opportunistic vaccination in Delhi, prospects of a single dose providing protection, and future availability of an affordable Indian vaccine shows promise for future widespread implementation and evaluation of HPV vaccination in India.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1470-2045(19)30531-5

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 2

  1. 2010, Concerns around the human papillomavirus (HPV) vaccine, Indian J Med Ethics, 7, 38
  2. Choudhury, 2010, Human papillomavirus vaccines and current controversy, Indian Paediatr, 47, 724

Cited by

Sorted by citations

See all 136

Related

See all

Metadata

Authors
Sankaranarayanan, R., Basu, P., Kaur, P., Bhaskar, R., Singh, G. B., Denzongpa, P., Grover, R. K., Sebastian, P., Saikia, T., Oswal, K., Kanodia, R., Dsouza, A., Mehrotra, R., Rath, G. K., Jaggi, V., Kashyap, S., Kataria, I., Hariprasad, R., Sasieni, P., Bhatla, N., Rajaraman, P., Trimble, E. L., Swaminathan, S., & Purushotham, A.
Affiliations
  • RTI International (US)
  • World Health Organization (CH)
  • Indian Council of Medical Research (IN)
  • Government of Sikkim (IN)
  • Delhi State Cancer Institute (IN)
  • Tata Trusts (IN)
  • Prince Aly Khan Hospital (IN)
  • DR. B.R.A. Institute Rotary Cancer Hospital (IN)
  • King's College London (GB)
  • All India Institute of Medical Sciences (IN)
  • United States Department of Health and Human Services (US)
  • National Cancer Institute (US)
Corresponding author
Basu, Partha
ORCID
Venue
The Lancet Oncology
Publisher
Elsevier BV
Published
2019-11
Volume
20
Issue
11
Pages
e637-e644
ISSN
1470-2045 (ISSN-L)
DOI
10.1016/s1470-2045(19)30531-5
OpenAlex
W2982439965
Cited by
136
References
42
Citations by year
2026: 13 · 2025: 16 · 2024: 27 · 2023: 18 · 2022: 24 · 2021: 21 · 2020: 17
FWCI
2.26
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • The Lancet Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
Indian Council of Medical Research
Topics
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
Keywords
HPV vaccination, cervical cancer prevention, adolescent girls, immunization programs, bivalent HPV vaccine, quadrivalent HPV vaccine, nonavalent HPV vaccine, India
MeSH terms
Uterine Cervical Neoplasms, Female, Health Policy, Humans, India, Policy Making, Prognosis, Risk Factors, Vaccination, Immunization Programs, Risk Assessment, Papillomavirus Infections, Papillomavirus Vaccines, Disease Eradication

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review